Authors: Cody, WL Augelli-Szafran, CE Berryman, KA Cai, CM Doherty, AM Edmunds, JJ He, JX Narasimhan, LS Penvose-Yi, J Plummer, JS Rapundalo, ST Rubin, JR Van Huis, CA Leblond, L Winocour, PD Siddiqui, MA

Citation: Wl. Cody et al., The design of potent and selective inhibitors of thrombin utilizing a piperazinedione template: Part 2, BIOORG MED, 9(17), 1999, pp. 2503-2508

Authors: Augelli-Szafran, CE Walker, LC LeVine, H

Citation: Ce. Augelli-szafran et al., beta-amyloid as a target for Alzheimer's disease therapy, ANNU REP M, 34, 1999, pp. 21-30

Authors: Augelli-Szafran, CE Blankley, CJ Jaen, JC Moreland, DW Nelson, CB Penvose-Yi, JR Schwarz, RD Thomas, AJ

Citation: Ce. Augelli-szafran et al., Identification and characterization of m1 selective muscarinic receptor antagonists, J MED CHEM, 42(3), 1999, pp. 356-363

Authors: St-Denis, Y Augelli-Szafran, CE Bachand, B Berryman, KA DiMaio, J Doherty, AM Edmunds, JJ Leblond, L Levesque, S Narasimhan, LS Penvose-Yi, JR Rubin, JR Tarazi, M Winocour, PD Siddiqui, MA

Citation: Y. St-denis et al., Potent bicyclic lactam inhibitors of thrombin: Part I: P3 modifications, BIOORG MED, 8(22), 1998, pp. 3193-3198